NCT03835923 - Lifestyle Intervention in Chronic Ischemic Heart Disease and Diabetes | Biotech Hunter

Enrollment

502

Participants

Timeline

Start Date

February 12, 2019

Primary Completion Date

December 16, 2020

Study Completion Date

April 16, 2021

Conditions

Ischemic Heart Disease ChronicDiabetes Mellitus, Type 2

Interventions

BEHAVIORAL

lifestyle intervention

"intervention phase 1 (baseline - month 6): Patients receive an individual exercise plan, nutritional recommendations and advices to increase daily activity. The intervention is accompanied by regular oral and written feedback.~intervention phase 2 (month 6 - month 12): Patients receive an individual exercise plan, nutritional recommendations and advices to increase daily activity without additional oral or written feedback."

BEHAVIORAL

usual care

Recommendation for lifestyle intervention at baseline and after 6 months (e.g. salt reduction, restricted alcohol consumption and smoking cessation, 10,000 steps/day, 150 minutes/week moderate intensity exercise)

Trial Locations (10)

Unknown

University Hospital: Rheinisch-Westfälische Technische Hochschule Aachen, Aachen

University Hospital: Charité - Universitätsmedizin Berlin, Berlin

University Hospital: Herzzentrum Dresden, Dresden

University Hospital: Universitäts-Herzzentrum Freiburg - Bad Krozingen, Freiburg im Breisgau

University Hospital: Universitätsmedizin Greifswald, Greifswald

Doctor's Practice: Dr. Rüdell, Kassel

University Hospital: Magdeburg, Magdeburg

University Hospital: Klinikum rechts der Isar, Technische Universität München, Munich

Doctor's Practice: Prof. Dr. Jacob und Dr. Jacob, Villingen-Schwenningen

04103

University Hospital: Klinik und Poliklinik für Kardiologie - Universitätsklinikum Leipzig, Leipzig